# OnCo record paper-latitude-lancet-oncol-2019-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-latitude-lancet-oncol-2019-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-latitude-lancet-oncol-2019-update" ;
  schema:name "Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial"@en ;
  schema:description "Later report from the LATITUDE trial registered as NCT01715285, in The Lancet Oncology (2019); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-latitude-lancet-oncol-2019-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(19)30082-8>, <https://pubmed.ncbi.nlm.nih.gov/30987939/>, <https://europepmc.org/article/MED/30987939>, <https://clinicaltrials.gov/study/NCT01715285> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(19)30082-8> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Fizazi K, Tran N, Fein L, et al." ;
  onco:trials <https://onco.cc/trials/latitude/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .